PCBD CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. PCBD Gen Silencer sind erhältlich als PCBD CRISPR/Cas9 Knockout Plasmide und PCBD Double Nickase Plasmide. PCBD CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
PCBD CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
PCBD1 CRISPR/Cas9 KO Plasmid (h) | sc-417347 | h | Gene Knockout | GFP | 0 | ||
PCBD1 HDR Plasmid (h) | sc-417347-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
PCBD1 Double Nickase Plasmid (h) | sc-417347-NIC | h | Gene Knockout | Puromycin | 0 | ||
PCBD1 Double Nickase Plasmid (h2) | sc-417347-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
PCBD1 CRISPR/Cas9 KO Plasmid (m) | sc-419960 | m | Gene Knockout | GFP | 0 | ||
PCBD1 HDR Plasmid (m) | sc-419960-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
PCBD1 Double Nickase Plasmid (m) | sc-419960-NIC | m | Gene Knockout | Puromycin | 0 | ||
PCBD1 Double Nickase Plasmid (m2) | sc-419960-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
PCBD2 CRISPR/Cas9 KO Plasmid (h) | sc-413554 | h | Gene Knockout | GFP | 0 | ||
PCBD2 HDR Plasmid (h) | sc-413554-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
PCBD2 Double Nickase Plasmid (h) | sc-413554-NIC | h | Gene Knockout | Puromycin | 0 | ||
PCBD2 Double Nickase Plasmid (h2) | sc-413554-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
PCBD2 CRISPR/Cas9 KO Plasmid (m) | sc-428379 | m | Gene Knockout | GFP | 0 | ||
PCBD2 HDR Plasmid (m) | sc-428379-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
PCBD2 Double Nickase Plasmid (m) | sc-428379-NIC | m | Gene Knockout | Puromycin | 0 | ||
PCBD2 Double Nickase Plasmid (m2) | sc-428379-NIC-2 | m | Gene Knockout | Puromycin | 0 |
PCBD CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
PCBD1 CRISPR Activation Plasmid (h) | sc-417347-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD1 CRISPR Activation Plasmid (h2) | sc-417347-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD1 Lentiviral Activation Particles (h) | sc-417347-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD1 Lentiviral Activation Particles (h2) | sc-417347-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD1 CRISPR Activation Plasmid (m) | sc-419960-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD1 CRISPR Activation Plasmid (m2) | sc-419960-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD1 Lentiviral Activation Particles (m) | sc-419960-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD1 Lentiviral Activation Particles (m2) | sc-419960-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD2 CRISPR Activation Plasmid (h) | sc-413554-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD2 CRISPR Activation Plasmid (h2) | sc-413554-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD2 Lentiviral Activation Particles (h) | sc-413554-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD2 Lentiviral Activation Particles (h2) | sc-413554-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD2 CRISPR Activation Plasmid (m) | sc-428379-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD2 CRISPR Activation Plasmid (m2) | sc-428379-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD2 Lentiviral Activation Particles (m) | sc-428379-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PCBD2 Lentiviral Activation Particles (m2) | sc-428379-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |